Alpine Immune Sciences, Inc. (ALPN): Price and Financial Metrics

ALPN POWR Grades

• ALPN scores best on the Sentiment dimension, with a Sentiment rank ahead of 86.33% of US stocks.
• ALPN's strongest trending metric is Growth; it's been moving up over the last 177 days.
• ALPN ranks lowest in Stability; there it ranks in the 17th percentile.

ALPN Stock Summary

• Of note is the ratio of ALPINE IMMUNE SCIENCES INC's sales and general administrative expense to its total operating expenses; just 7.7% of US stocks have a lower such ratio.
• With a price/sales ratio of 20.64, ALPINE IMMUNE SCIENCES INC has a higher such ratio than 94.9% of stocks in our set.
• With a year-over-year growth in debt of -38.7%, ALPINE IMMUNE SCIENCES INC's debt growth rate surpasses only 8.11% of about US stocks.
• If you're looking for stocks that are quantitatively similar to ALPINE IMMUNE SCIENCES INC, a group of peers worth examining would be CARA, ABUS, ALT, IDYA, and VIR.
• ALPN's SEC filings can be seen here. And to visit ALPINE IMMUNE SCIENCES INC's official web site, go to www.alpineimmunesciences.com.

ALPN Valuation Summary

• ALPN's price/earnings ratio is -13.5; this is 155.56% lower than that of the median Healthcare stock.
• Over the past 102 months, ALPN's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for ALPN.

ALPN Growth Metrics

The year over year net income to common stockholders growth rate now stands at -42.87%.
• Its 2 year price growth rate is now at 120%.
• Its 5 year net income to common stockholders growth rate is now at -7.57%.

Over the past 33 months, ALPN's revenue has gone up $30,078,000.

The table below shows ALPN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	31.818	-41.697	-54.065
2022-06-30	31.967	4.785	-54.286
2022-03-31	33.868	6.172	-47.217
2021-12-31	23.443	-15.248	-50.333
2021-09-30	24.556	-9.868	-41.508
2021-06-30	17.953	-45.394	-34.151

ALPN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ALPN has a Quality Grade of C, ranking ahead of 68.11% of graded US stocks.
• ALPN's asset turnover comes in at 0.122 -- ranking 247th of 682 Pharmaceutical Products stocks.
• SELB, TXMD, and QGEN are the stocks whose asset turnover ratios are most correlated with ALPN.

The table below shows ALPN's key quality metrics over time.